32 related articles for article (PubMed ID: 7875111)
1. Long-Term Outcome of Clozapine in Treatment-Resistant Schizophrenia.
Lee MA; Cola P; Jayathilake K; Meltzer HY
J Clin Psychopharmacol; 2023 May-Jun 01; 43(3):211-219. PubMed ID: 36975722
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory markers in outpatients with schizophrenia diagnosis in regular use of clozapine: a cross-sectional study.
Cordova VHS; Teixeira AD; Anzolin AP; Moschetta R; Belmonte-de-Abreu PS
Front Psychiatry; 2023; 14():1269322. PubMed ID: 37876624
[TBL] [Abstract][Full Text] [Related]
3. Long-term treatment with atypical antipsychotics and the risk of weight gain : a literature analysis.
Gentile S
Drug Saf; 2006; 29(4):303-19. PubMed ID: 16569080
[TBL] [Abstract][Full Text] [Related]
4. Bodyweight gain with atypical antipsychotics. A comparative review.
Wetterling T
Drug Saf; 2001 Jan; 24(1):59-73. PubMed ID: 11219487
[TBL] [Abstract][Full Text] [Related]
5. [A new therapeutic approach tp drug-resistant schizophrenia: clozapine. Long-term prospective study in 16 patients].
Jalenques I; Coudert AJ
Acta Psychiatr Belg; 1992; 92(6):323-38. PubMed ID: 1364281
[TBL] [Abstract][Full Text] [Related]
6. [Long-term clinical experience with clozapine].
Gelly F; Chambon O; Marie-Cardine M
Encephale; 1997; 23(5):385-96. PubMed ID: 9453932
[TBL] [Abstract][Full Text] [Related]
7. [Clinical effects of clozapine: effect on negative symptoms].
Llorca PM; Lançon C; Auquier P; Bougerol T
Encephale; 1996; 22(4):287-92. PubMed ID: 9035984
[TBL] [Abstract][Full Text] [Related]
8. Clozapine-induced QEEG changes correlate with clinical response in schizophrenic patients: a prospective, longitudinal study.
Gross A; Joutsiniemi SL; Rimon R; Appelberg B
Pharmacopsychiatry; 2004 May; 37(3):119-22. PubMed ID: 15138895
[TBL] [Abstract][Full Text] [Related]
9. Nonresponse to clozapine and premorbid functioning in treatment of refractory schizophrenia.
Kelly DL; Feldman S; Boggs DL; Gale E; Conley RR
Compr Psychiatry; 2010; 51(3):298-302. PubMed ID: 20399340
[TBL] [Abstract][Full Text] [Related]
10. [Clozapine and refractory schizophrenia. Long-term prospective study of 20 patients].
Jalenques I; Coudert AJ
Encephale; 1994; 20(6):767-75. PubMed ID: 7875111
[TBL] [Abstract][Full Text] [Related]
11. Dimensions of outcome with clozapine.
Meltzer HY
Br J Psychiatry Suppl; 1992 May; (17):46-53. PubMed ID: 1418889
[TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy of clozapine in treatment-refractory schizophrenia: an overview.
Kane JM
Br J Psychiatry Suppl; 1992 May; (17):41-5. PubMed ID: 1418888
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
